Clinical Trial Update: Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating the efficacy and safety of gemigliptin 50 mg once daily in combination with metformin for Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gemigliptin (gemigliptin)
• metformin (metformin)

Snippet

Sponsor: LG Life Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED